Plus   Neg

Royalty Pharma Buys Dicerna's Royalty Interest In OXLUMO

Royalty Pharma plc (RPRX) has acquired Dicerna Pharmaceuticals Inc.'s (DRNA) royalty interest in OXLUMO or lumasiran for an upfront cash payment of $180 million and up to $60 million in contingent sales-based milestone payments.

OXLUMO, which has been approved by the U.S. Food and Drug Administration and European Medicines Agency for the treatment of primary hyperoxaluria type 1, is marketed by Alnylam Pharmaceuticals Inc.

Dicerna is entitled to royalties in the mid to high single digits based on OXLUMO global net sales.

Dicerna said that it expects the transaction, together with its cash, cash equivalents, held-to-maturity investments and anticipated milestone and other payments from existing collaborations, to extend its projected cash runway and be sufficient to fund the execution of its current clinical and operating plan into 2024.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Guan's Mushroom Co. is recalling all cases of its 200g/7.05-ounce packages of Enoki Mushroom citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recalled Enoki is a product of China and comes in a clear plastic package with the description "Enoki Mushroom" in English, Korean and French, and Guan's logo in the front. Shares of Roche were gaining around 2 percent in Swiss trading after the drug major reported Wednesday a 3 percent rise in first-quarter sales at constant currency basis mainly driven by strong growth in Diagnostics Division. Sales, on a reported basis, edged down 1 percent mainly with significant impact from biosimilars. Looking ahead for fiscal 2021, the company continues to expect sales to grow Church & Dwight Co., Inc. is recalling select vitafusion gummy products due to isolated manufacturing issue, the U.S. Food and Drug Administration said. The recall was initiated after the company's investigation of two consumer reports identified the possible presence of a metallic mesh material in product lots manufactured in a four-day period between October 29 and November 3, 2020.
Follow RTT